(NP (NP (NN Motivation)) (: :) (S (NP (PRP We)) (VP (VBP investigate) (SBAR (IN whether) (S (NP (DT a) (JJ template-based) (NN classification) (NN pipeline)) (VP (MD could) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VP (VB identify) (NP (NNS immunophenotypes)) (PP (IN in))) (PRN (-LRB- -LRB-) (CC and) (VP (ADVP (RB thereby)) (VB classify)) (-RRB- -RRB-)) (NP (NP (DT a) (JJ heterogeneous) (NN disease)) (PP (IN with) (NP (JJ many) (NNS subtypes)))))))))))))) (. .))
(S (NP (NP (DT The) (NN disease)) (SBAR (S (NP (PRP we)) (VP (VBP consider) (ADVP (RB here)))))) (VP (VBZ is) (NP (NP (NNP Acute) (NNP Myeloid) (NNP Leukemia)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (JJ heterogeneous)) (PP (IN at) (NP (DT the) (UCP (NN morphologic) (, ,) (JJ cytogenetic) (CC and) (JJ molecular)) (NNS levels))) (, ,) (PP (IN with) (NP (JJ several) (VBN known) (NNS subtypes)))))))) (. .))
(S (NP (NP (DT The) (NN prognosis) (CC and) (NN treatment)) (PP (IN for) (NP (NNP AML)))) (VP (VBZ depends) (PP (IN on) (NP (DT the) (NN subtype)))) (. .))
(NP (NP (NNS Results)) (: :) (S (NP (PRP We)) (VP (VBP apply) (NP (NP (RB flowMatch)) (, ,) (NP (NP (DT an) (JJ algorithmic) (NN pipeline)) (PP (IN for) (NP (JJ flow) (NN cytometry) (NNS data))) (VP (VBN created) (PP (IN in) (NP (JJR earlier) (NN work))))) (, ,)) (S (VP (TO to) (VP (VB compute) (NP (NP (NNS templates)) (VP (ADVP (RB succinctly)) (VBG summarizing) (NP (NP (NP (NNS classes)) (PP (IN of) (NP (NNP AML)))) (CC and) (NP (JJ healthy) (NNS samples)))))))))) (. .))
(S (NP (PRP We)) (VP (VBP develop) (NP (NP (DT a) (NN scoring) (NN function)) (SBAR (WHNP (WDT that)) (S (VP (VBZ accounts) (PP (IN for) (NP (NP (NNS features)) (PP (IN of) (NP (DT the) (NNP AML) (NNS data))) (PP (JJ such) (IN as) (NP (NN heterogeneity))))) (S (VP (TO to) (VP (VB identify) (NP (NP (NNS immunophenotypes)) (VP (VBG corresponding) (PP (TO to) (NP (NP (JJ various) (NNP AML) (NNS subtypes)) (, ,) (PP (VBG including) (NP (NNP APL))))))))))))))) (. .))
(S (NP (NP (DT All)) (PP (IN of) (NP (NP (DT the) (NNP AML) (NNS samples)) (PP (IN in) (NP (DT the) (NN test) (NN set)))))) (VP (VBP are) (VP (VBN classified) (ADVP (RB correctly)) (PP (IN with) (NP (JJ high) (NN confidence))))) (. .))
(NP (NP (NN Availability)) (: :) (S (S (NP (NN flowMatch)) (VP (VBZ is) (ADJP (JJ available)) (PP (IN at) (NP (NN www.bioconductor.org/packages/devel/bioc/html/flowMatch.html))))) (: ;) (S (NP (NP (NNS programs)) (ADJP (VBP specific) (PP (TO to) (S (VP (VBG immunophenotyping) (NP (NNP AML))))))) (VP (VBP are) (PP (IN at) (NP (NN www.cs.purdue.edu/homes/aazad/software.html)))))) (. .))
